SCHEMBL2374130

SCHEMBL2374130

CCOC(=O)C(Cc1ccon1)NCc1ccc(-c2ccncc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPID Q08752 1/20 0.47
CDC7 O00311 6/20 0.36
DBF4 Q9UBU7 6/20 0.36
HDAC1 Q13547 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HTT P42858 1/20 0.36
GPR142 Q7Z601 2/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
CYP26A1 O43174 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
MMP2 P08253 1/20 0.34
MMP13 P45452 1/20 0.34
MMP14 P50281 1/20 0.34
GAA P10253 1/20 0.34
NAMPT P43490 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2373510 0.80 PPID (0.50) PPIDCDC7DBF4HDAC1GPR142
SCHEMBL2375909 0.71 GPR142 (0.47) PPIDHDAC1GPR142CYP26A1ROCK2
SCHEMBL2374561 0.70 PPID (0.48) PPIDHDAC1GPR142PDCD1CD274
SCHEMBL2374570 0.70 PPID (0.48) PPIDHDAC1GPR142PDCD1CD274
SCHEMBL2376148 0.70 PPID (0.41) PPIDHDAC1GPR142POLBKMT2A
SCHEMBL1124572 0.69 ALDH1A1 (0.40) ALDH1A1POLBKMT2AMEN1CYP3A4
Hydrochloric Acid SCHEMBL21879064 0.68 ALDH1A1 (0.39) ALDH1A1POLBPKMKMT2AMEN1
SCHEMBL1931193 0.67 MMP8 (0.56) PPIDPOLB
SCHEMBL29788300 0.67 MAPT (0.49) PPIDALDH1A1POLBMAPTKMT2A
SCHEMBL13915549 0.67 MMP8 (0.56) PPIDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110224210-A1 NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS ACTELION PHARMACEUTICALS LTD. (CH) 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224210-A1 NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS CTSA, BECN1, HDAC6 PPID 654/4885CDC7 3765/4885DBF4 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.